Carysil Board of Directors

Get the latest insights into the leadership at Carysil. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Chirag Parekh Chairman & Managing Director
Mr. Anand Sharma Executive Director & Group CFO
Dr. Sonal V Ambani Independent Director
Mr. Rustam N Mulla Independent Director
Mrs. Katja Larsen Independent Director
Mr. Prabhakar R Dalal Independent Director
Mr. Pradyumna R Vyas Independent Director
Dr. Savan Godiawala Independent Director

Carysil Share price

CARYSIL

894.4

3.55 (-0.40%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:49 IST
BUYSELL
Today's High

935.95

Today's Low

885.60

52 Week Low

482.30

52 Week High

947.00

The current prices are delayed, login to your account for live prices

Carysil FAQs

The board at Carysil consists of experienced professionals, including Mr. Chirag Parekh , Mr. Anand Sharma , and others, overseeing the company’s strategic and corporate governance.

Directors at Carysil are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Chirag Parekh is the current chairman at Carysil.

Executive directors at Carysil are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Carysil adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Carysil, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.